StealthCo is a seed-stage techbio company, created within DSV, building a computational drug discovery platform that constructs causal biological networks from large-scale primary human single-cell omics data and structured published experimental literature. Our multi-agent AI system reasons over these networks to generate, simulate, and rank mechanistic hypotheses for combination therapies — with system accuracy verified against top-tier researchers at the Allen Institute. We will initially focus on oncology indications.
You will design and build production bioinformatics pipelines for new modalities—spatial transcriptomics, single-cell proteomics, and spatial proteomics—extending our existing scRNA-seq infrastructure. These pipelines feed directly into an agentic hypothesis generation system: the quality of what goes in determines the quality of every therapeutic hypothesis that comes out.
You’ll work closely with our Head of AI & Technology (Dr. Francesco Moramarco) and Head of Platform (Dr. Moustafa Khedr) to:
Requirements
Strong desirables
Nice to have
We know job descriptions like this can read as a wish list. If you don't tick every box, but believe you can build what we need - apply anyway! We care more about what you've built and how you think than whether your CV maps perfectly to every bullet point.
Benefits
Competitive compensation commensurate with experience and profile, plus equity participation. Flexible arrangement depending on location and preference (full-time employment or long-term consultancy). Small, technically intense team with high autonomy and ownership. Remote-first. Minimal management layers and direct impact on decisions.